<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01765829</url>
  </required_header>
  <id_info>
    <org_study_id>NONSTOP</org_study_id>
    <nct_id>NCT01765829</nct_id>
  </id_info>
  <brief_title>Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis</brief_title>
  <acronym>NONSTOP</acronym>
  <official_title>Randomized Multicentric Open-label Phase III Clinical Trial to Evaluate the Efficacy of Continual Treatment Versus Discontinuation Based in the Presence of Prodromes in a First Episode of Non-affective Psychosis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Pública Andaluza Progreso y Salud</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess if patients who continue with antipsychotic treatment
      for 12 or more months show the same risk of relapse (measured by PANSS) that patients with
      the same medical condition who have followed a discontinuation treatment scheme based in the
      presence of prodromes.

      The candidates should accomplish the following criteria: first episode of non-affective
      psychosis who have followed antipsychotic treatment for 12 months and who have already shown
      remission criteria.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized, open label, multicenter, phase III clinical trial. Number of subjects: 104. Age
      range: 18 - 55 years of both sex.

      Timepoints for evaluation: Every two weeks, during the first six months after initiation of
      treatment discontinuation/continuation. Every four weeks during the remaining six months, to
      complete a total follow-up scheme of 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Risk of relapse</measure>
    <time_frame>12 months</time_frame>
    <description>The purpose of this study is to assess if patients who continue with antipsychotic treatment for 12 or more months show the same risk of relapse (measured by PANSS) that patients with the same medical condition who have followed a discontinuation treatment scheme based in the presence of prodromes.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">104</enrollment>
  <condition>Psychosis Nos/Other</condition>
  <arm_group>
    <arm_group_label>Antipsychotic treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Antipsychotic treatment according to common clinical practice
Drugs: Aripiprazole, Olanzapine, Zuclopenthixol, Clotiapine, Flupentixol, Risperidone, Sulpiride, Trifluoperazine, Haloperidol, Quetiapine, Paliperidone, Chlorpromazine, Pipotiazine, Flufenazine, Periciazine, Clozapine, Pimozide, Perfenazine, Sertindole, Levomepromazine, Amisulpride, Asenapine, Tiapride, Droperidol, Ziprasidone.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Discontinuation antipsychotic treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dose reduction of antipsychotic treatment (25% every 4 weeks).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Discontinuation antipsychotic treatment</intervention_name>
    <description>Dose reduction until withdrawal</description>
    <arm_group_label>Discontinuation antipsychotic treatment</arm_group_label>
    <other_name>Aripiprazole</other_name>
    <other_name>Olanzapine</other_name>
    <other_name>Zuclopenthixol</other_name>
    <other_name>Clotiapine</other_name>
    <other_name>Flupentixol</other_name>
    <other_name>Risperidone</other_name>
    <other_name>Sulpiride</other_name>
    <other_name>Trifluoperazine</other_name>
    <other_name>Haloperidol</other_name>
    <other_name>Quetiapine</other_name>
    <other_name>Paliperidone</other_name>
    <other_name>Chlorpromazine</other_name>
    <other_name>Pipotiazine</other_name>
    <other_name>Flufenazine</other_name>
    <other_name>Periciazine</other_name>
    <other_name>Clozapine</other_name>
    <other_name>Pimozide</other_name>
    <other_name>Perfenazine</other_name>
    <other_name>Sertindole</other_name>
    <other_name>Levomepromazine</other_name>
    <other_name>Amisulpride</other_name>
    <other_name>Asenapine</other_name>
    <other_name>Tiapride</other_name>
    <other_name>Droperidol</other_name>
    <other_name>Ziprasidone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antipsychotic treatment</intervention_name>
    <description>Antipsychotic treatment is not modify during the study, it is administered according to common clinical practice</description>
    <arm_group_label>Antipsychotic treatment</arm_group_label>
    <other_name>Antipsychotic drugs</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult age from 18 to 55 years old

          -  Non-affective psychosis diagnosis (schizophrenia, schizoaffective, schizophreniform
             disorders, acute psychosis, other psychosis according to Diagnostic and Statistical
             Manual of Mental Disorders, Fourth Edition (DSM-IV).

          -  Antipsychotic treatment for 12 months since clinical stabilization. Clinical
             stabilization is defined in case of admission by medical discharge (not including
             voluntary discharge). In case of voluntary discharge or no admission to hospital,
             clinical stabilization can be defined by the psychiatrist according to medical history
             and the information provided by the family.

          -  No changes in the antipsychotic doses in the last 4 months.

          -  No suicide attempts in the last 12 months.

          -  Patient who shows remission criteria.

          -  Signed informed consent form.

        Exclusion Criteria:

          -  Patient who is not fluent in Spanish language

          -  Patient who takes mood stabilizers (Lithium, antiepileptic drugs...)

          -  Dependency on alcohol or other substances of abuse (cannabis, cocaine...)

          -  History of brain injury with loss of consciousness for more than 1 hour, stroke or
             other central nervous system disorders.

          -  Intelligence testing (IQ) less than 70.

          -  Suicide attempt from stabilization.

          -  Pregnancy or planning to become pregnant during the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miguel Ruiz Veguilla, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Virgen del Rocío Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clara M. Rosso Fernández, MD</last_name>
    <phone>0034955013414</phone>
    <email>claram.rosso.sspa@juntadeandalucia.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Miguel Ruiz Veguilla, MD, PhD</last_name>
    <phone>0034955013414</phone>
    <email>mruizveguilla@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mental Health Unit Villamartín</name>
      <address>
        <city>Villamartín</city>
        <state>Cádiz</state>
        <zip>11650</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José María Mongil San Juan, MD</last_name>
      <phone>0034956040209</phone>
      <email>cheman45@gmail.com</email>
    </contact>
    <investigator>
      <last_name>José María Mongil San Juan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mental Health Unit Baza</name>
      <address>
        <city>Baza</city>
        <state>Granada</state>
        <zip>18800</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Bravo Barba, MD</last_name>
      <email>eva.bravo.barba@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Eva Bravo Barba, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mental Health Unit Motril</name>
      <address>
        <city>Motril</city>
        <state>Granada</state>
        <zip>18600</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>María Luisa Barrigón Estévez, MD</last_name>
      <phone>0034958038849</phone>
      <email>marial.barrigon.sspa@juntadeandalucia.es</email>
    </contact>
    <investigator>
      <last_name>María Luisa Barrigón Estévez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mental Health Unit Andújar</name>
      <address>
        <city>Andújar</city>
        <state>Jaén</state>
        <zip>23740</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernando Sarramea Crespo, MD, PhD</last_name>
      <phone>0034953021717</phone>
      <email>fernandosarramea@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Farnando Sarramea Crespo, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mental Health Unit Martos</name>
      <address>
        <city>Martos</city>
        <state>Jaén</state>
        <zip>23600</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Ortigosa Luque, MD</last_name>
      <email>migueortigosa@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Miguel Ortigosa Luque, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mental Health Unit Miraflores</name>
      <address>
        <city>Alcobendas</city>
        <state>Madrid</state>
        <zip>28100</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>María Luisa Zamarro Arraz, MD, PhD</last_name>
      <phone>0034916530108</phone>
      <email>zamarroluisa@yahoo.es</email>
    </contact>
    <investigator>
      <last_name>María Luisa Zamarro Arraz, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Infanta Sofía</name>
      <address>
        <city>San Sebastian de los Reyes</city>
        <state>Madrid</state>
        <zip>28702</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>María Rosario Gutiérrez Labrador, MD</last_name>
      <email>rosagutierrez@psiquiatra.e.telefonica.net</email>
    </contact>
    <investigator>
      <last_name>María Rosario Guitiérrez Labrador, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mental Health Unit Valle del Guadalhorce</name>
      <address>
        <city>Cártama</city>
        <state>Málaga</state>
        <zip>29580</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel Gutiérrez Castillo, MD</last_name>
      <phone>0034951033931</phone>
      <email>dgutierrezcastillo@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Daniel Gutiérrez Castillo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mental Health Unit Las Lagunas</name>
      <address>
        <city>Fuengiróla</city>
        <state>Málaga</state>
        <zip>29650</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>María Isabel Osuna Carmona, MD</last_name>
      <email>maribelosunac@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>María Isabel Osuna Carmona, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fundación Argibide</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <zip>31007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ignacio Mata Pastor, MD, PhD</last_name>
      <phone>0034948266650</phone>
      <email>nacho.mata70@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ignacio Mata Pastor, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital El Tomillar</name>
      <address>
        <city>Dos Hermanas</city>
        <state>Seville</state>
        <zip>41700</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joaquín Carlos Martín Muñoz, MD, PhD</last_name>
      <phone>0034955016083</phone>
      <email>joaquinmartin@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Joaquín Carlos Martín Muñoz, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Francesc de Borja</name>
      <address>
        <city>Gandía</city>
        <state>Valencia</state>
        <zip>46700</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>María Lacruz Silvestre, MD, PhD</last_name>
      <email>maria.lacruz.silvestre@gmail.com</email>
    </contact>
    <investigator>
      <last_name>María Lacruz Silvestre, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Basurto</name>
      <address>
        <city>Bilbao</city>
        <zip>48013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sonia Bustamante Madariaga, MD, Phd</last_name>
      <phone>0034944 006137</phone>
      <email>sonia.bustamantemadariaga@osakidetza.net</email>
    </contact>
    <investigator>
      <last_name>Sonia Bustamante Madariaga, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mental Health Unit Tetuán</name>
      <address>
        <city>Madrid</city>
        <zip>28003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mariano Hernández Monsalve, MD, PhD</last_name>
      <phone>0034915347363</phone>
      <email>hergoico@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ruth Berdún Pe, MD</last_name>
      <email>ruthberdun@yahoo.es</email>
    </contact_backup>
    <investigator>
      <last_name>Mariano Hernández Monsalve, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lafora Hospital</name>
      <address>
        <city>Madrid</city>
        <zip>28049</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juan Dios Molina Martín, MD, PhD</last_name>
      <email>jmolinamar@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Juan Dios Molina Martín, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Carlos Haya</name>
      <address>
        <city>Málaga</city>
        <zip>29009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fermín Mayoral Cleríes, Md, PhD</last_name>
      <email>fermin.mayoral.sspa@juntadeandalucia.es</email>
    </contact>
    <investigator>
      <last_name>Fermín Mayoral Cleríes, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virgen del Rocío Hospital</name>
      <address>
        <city>Seville</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clara M. Rosso Fernández, MD</last_name>
      <phone>0034955013414</phone>
      <email>claram.rosso.sspa@juntadeandalucia.es</email>
    </contact>
    <contact_backup>
      <last_name>Miguel Ruiz Veguilla, MD, PhD</last_name>
      <phone>0034955013414</phone>
      <email>mruizveguilla@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Miguel Ruiz Veguilla, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2013</study_first_submitted>
  <study_first_submitted_qc>January 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 10, 2013</study_first_posted>
  <last_update_submitted>December 4, 2014</last_update_submitted>
  <last_update_submitted_qc>December 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Non Affective Psychosis</keyword>
  <keyword>First episode</keyword>
  <keyword>Discontinuation scheme</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychotic Disorders</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Risperidone</mesh_term>
    <mesh_term>Paliperidone Palmitate</mesh_term>
    <mesh_term>Ziprasidone</mesh_term>
    <mesh_term>Clozapine</mesh_term>
    <mesh_term>Antipsychotic Agents</mesh_term>
    <mesh_term>Aripiprazole</mesh_term>
    <mesh_term>Olanzapine</mesh_term>
    <mesh_term>Quetiapine Fumarate</mesh_term>
    <mesh_term>Haloperidol</mesh_term>
    <mesh_term>Haloperidol decanoate</mesh_term>
    <mesh_term>Asenapine</mesh_term>
    <mesh_term>Sultopride</mesh_term>
    <mesh_term>Droperidol</mesh_term>
    <mesh_term>Chlorpromazine</mesh_term>
    <mesh_term>Sertindole</mesh_term>
    <mesh_term>Flupenthixol</mesh_term>
    <mesh_term>Perphenazine</mesh_term>
    <mesh_term>Pimozide</mesh_term>
    <mesh_term>Sulpiride</mesh_term>
    <mesh_term>Tiapride Hydrochloride</mesh_term>
    <mesh_term>Trifluoperazine</mesh_term>
    <mesh_term>Methotrimeprazine</mesh_term>
    <mesh_term>Clopenthixol</mesh_term>
    <mesh_term>Clothiapine</mesh_term>
    <mesh_term>Flupenthixol decanoate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

